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Abstract
The Parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium (MPP) causes specific cell death in dopaminergic
neurons after accumulation by the dopamine transporter (DAT). COS cells, a non-neuronal cell line insensitive to high doses
of MPP, becomes sensitive to MPP when transfected with the rat DAT cDNA. We analyzed the bi-directional transport of
MPP and its toxicity in several cell lines expressing wild or mutant DATs. Cell death in COS cells expressing wild DAT by
exposure to MPP was concentration-dependent and cocaine-reversible. Increased wild DAT expression caused higher
sensitivities to the toxin in HeLa cells. Although several mutant DATs demonstrated greater transport activity than the wild-
type, they displayed similar or lower sensitivity to MPP toxicity. Reverse transport of preloaded [3H]MPP through DAT
was facilitated in COS cells expressing certain mutant DATs, which consistently displayed less sensitivity to MPP toxicity.
These results suggest that re-distribution of MPP due to influx/efflux turnover through the transporter is a key factor in
MPP toxicity. 0167-4889 / 98 / $ ^ see front matter ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
1-Methyl-4-phenylpyridinium (MPP), an active
metabolite of the Parkinsonism-inducing neuro-
toxin N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
(MTPT), causes speci¢c cell death in dopaminergic
neurons after accumulation by the dopamine trans-
porter (DAT) ([1^4], see review [5]). Although nu-
merous attempts have been made to clarify the ac-
tion of MPP, several questions remain to be
answered, including species di¡erences in sensitivity
to MPTP toxicity. One reason rats are relatively in-
sensitive to MPTP may be the low activity of MAOB,
which catalyzes MPTP to MPP [5]. At present,
however, this is not an entirely convincing explana-
tion.
Molecular cloning of DAT opens new avenues for
investigating the action of MPP [6,7]. We have
demonstrated that COS cells, a non-neuronal cell
line insensitive to MPP even at high concentrations,
become sensitive to MPP when transfected with the
rat DAT [8]. Pi£ et al. [9] demonstrated MPP tox-
icity in di¡erent cell lines expressing human DAT.
Using DAT and norepinephrine transporter (NET),
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they analyzed the properties of the transporters that
may be involved in MPP toxicity and suggested the
importance of the initial velocity of uptake by the
transporter rather than a⁄nity for substrate [10].
However, this speculation have not been con¢rmed
experimentally.
Recently, we reported the reverse transport of
dopamine (DA) and MPP through expressed rat
DAT in COS cells [11] and in Xenopus laevis oocyte
[12]. The nature of the e¥ux of MPP through the
DAT expressed in COS cells was quite di¡erent from
that of DA: persistent e¥ux of [3H]MPP was ob-
served and more than 70% of preloaded [3H]MPP
was released during initial 15 min incubation. These
results suggested that re-distribution of accumulated
MPP through reverse transport across the plasma
membrane may occur quickly, a¡ecting toxicity.
To analyze the relationship between transporter
activity and MPP toxicity, we examined the
MPP toxicity in COS cells expressing wild and var-
ious mutant DATs including 7S-A2 mutant DAT,
which revealed a marked increase in initial velocity
(Vmax) for MPP uptake [13]. Contrary to our pre-
diction, sensitivity to MPP toxicity decreased in the
COS cells expressing the 7S-A2 mutant DAT. To
resolve this apparent discrepancy, we focused on
the role of MPP release through the DAT in the
expression of toxicity in several cell lines expressing
wild or mutant DATs with di¡erent kinetic proper-
ties.
2. Materials and methods
2.1. Expression of DAT
COS cells were transfected with 20 Wg pcDNAI or
pcDNA3 carrying wild or mutant rat DAT cDNA
by electroporation [14]. The cells were then diluted in
culture medium (DMEM + 10% FCS), plated in 24-
well plate (for uptake and e¥ux assay) or 96-well
plate (for MPP toxicity assay), and cultured for
2^4 days.
Stable cell lines expressing DAT were made by
transfection of HeLa cells with pcDNA3 carrying
rat DAT and selected by G418 (600 Wg/ml) and
[3H]DA uptake [15]. One month after G418 treat-
ment, 4 of 25 clones resistant to G418 treatment
showed high to low ability to take up [3H]DA. Those
were designated HeLa/DAT B5, D2, B2, C5, respec-
tively, and analyzed further.
2.2. MPP toxicity assay
One-day cultures after electroporation were
washed with Hank’s balanced salt solution (HBSS),
then incubated in culture medium containing di¡er-
ent concentrations of MPP with or without 100 WM
cocaine under culture condition for 2 days. Cells
were then subjected for microscopic analysis. The
quantitative toxicity assay used WST-1 (2-(4-iodo-
phenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-
tetrazolium) (Dojindo, Kumamoto, Japan), a water
soluble folmazan dye, which re£ects mitochondrial
respiratory activity [16]. Optical density (OD) was
measured using microplate reader (Tosoh, Tokyo,
Japan) at 450 nm, 1, 2 and 3 h after incubation
with WST-1 (10 Wl of 5 mM WST-1 per 100 Wl of
culture).
In some experiments, release of lactate dehydro-
genase (LDH) into the culture medium was measured
for evaluation of MPP toxicity. After a 1-h incuba-
tion of cells with various concentrations of MPP,
cells were washed three times with HBSS, incubated
with toxin-free HBSS for 3 h, then the LDH released
into the incubation solution was measured colorimet-
rically according to the manufacturer’s protocol
(Wako, Tokyo, Japan).
2.3. Uptake and e¥ux assay
Procedures for assaying uptake and e¥ux of radio-
labeled ligands have been described elsewhere [11].
Brie£y, transfected and cultured cells were washed
with Krebs Ringer HEPES-bu¡ered solution
(KRH) containing 0.1% BSA, incubated with 100
nM [3H]DA (888 GBq/mmol, NEN DuPont) or
[3H]MPP (2956.3 GBq/mmol, NEN DuPont) at
37‡C for 10 min. The [3H]DA or [3H]MPP uptake
was separated by rapid wash of cells with ice-cold
KRH, and the radioactivity extracted by 2 N
NaOH was determined by liquid scintillation count-
ing. Non-speci¢c uptake was determined in the pres-
ence of 100 WM cocaine.
For the e¥ux study, cells were preloaded with
10 nM [3H]MPP at 37‡C for 30 min, washed with
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KRH, then incubated in fresh KRH containing test
compounds. The incubation medium was separated
rapidly from the culture well, and the radioactivity in
the medium along with that remaining in the cells
were separately measured by liquid scintillation
counting. Release of [3H]MPP was expressed as a
percent of total cell content initially present at the
start of incubation (sum of those in the medium and
in the cells at the end of incubation).
2.4. Construction of mutant DATs by site-directed
mutagenesis
In vitro mutagenesis of rat DATs was performed
by the method described previously [13,14], except
Y533A and Y533F [15].
Two serines S353 and S355 located in putative 7th
transmembrane region were replaced by alanine (des-
ignated 7S-A2) [14]. Tyrosine-251 and tyrosine-273
located in the putative 4th and 5th transmembrane
regions, respectively, were replaced by alanine, and
designated Y251A, Y273A.
Y533A and Y533F, in which tyrosine-533 located
in the putative 11th transmembrane region was re-
placed by alanine (Y533A) or phenylalanine
(Y533F), were constructed by PCR-based mutagene-
sis according to manufacturer’s protocol (Stratagene)
[15].
3. Results
In the present study, we examined the relationship
between MPP toxicity and MPP transport
through the plasma membrane via DAT in several
cell lines expressing wild and mutant DATs. The aim
of using mutant DATs with di¡erent transport prop-
erties was to isolate the transporter functions impor-
tant for MPP toxicity.
We have demonstrated that COS cells, a non-neu-
ronal cell line insensitive to high doses of MPP,
become sensitive to MPP toxicity when transfected
with the rat DAT cDNA [8]. Fig. 1 shows the e¡ect
of MPP on cell viability in COS cells expressing the
wild DAT. Using WST-1, a dye indicator of mito-
chondrial respiration, quantitative analysis of MPP
Fig. 1. E¡ects of MPP exposure on cell viability in COS cells expressing wild rat DAT. Quantitative analysis of MPP toxicity was
performed using WST-1. (A) Two days exposure of COS cells expressing wild rat DAT to various concentrations of MPP with or
without 100 WM cocaine. (B) MPP toxicity in control COS cells mock-transfected with pcDNA3 vector. Points and bars represent
the mean þ S.E.M., n = 4. *Signi¢cantly di¡erent from control (without MPP) at P6 0.01 analyzed by Student’s t-test. #P6 0.05 vs.
without cocaine. Following statistical analyses were performed in the same way.
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toxicity was performed in COS cells. When cells were
transfected with rat DAT, MPP caused cell death in
a concentration-dependent fashion. Cocaine compet-
itively blocked the e¡ect. Mock-transfected COS cells
showed less sensitivity to MPP toxicity and cocaine
was without e¡ect.
Increased DAT expression in selected clones of the
transfected HeLa cells revealed greater sensitivity to
Fig. 2. MPP toxicity in HeLa cells stably expressing wild rat DAT. (A) Kinetics of [3H]dopamine uptake in HeLa cells di¡erently ex-
pressing the rat DAT, clone B5, D2, B2 and C5. (B) Time-course of [3H]MPP uptake in four di¡erent clones of HeLa cells. (C)
MPP toxicity in four di¡erent clones of HeLa cells, assessed by WST-1 and expressed as % of control (without MPP). Points and
bars represent the mean þ S.E.M., n = 3^4. *P6 0.05 vs. control (without MPP).
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MPP toxicity (Fig. 2C) in parallel to DA uptake
velocity (Fig. 2A) and MPP transport (Fig. 2B).
These results suggest that transporter expression or
transport activity is related to MPP toxicity.
Given this rationale, we ¢rst examined MPP tox-
icity in COS cells expressing the 7S-A2 mutant DAT,
which shows increased initial velocity (Vmax) for
MPP uptake [13]. Contrary to our hypothesis, these
cells showed less sensitivity to MPP toxicity, as
shown in Fig. 3. These results indicate that uptake
velocity is not unnecessarily related to MPP toxic-
ity. Although MPP must be taken up into cells to
be toxic, the kinetics of uptake over a short time
cannot predict toxicity.
To resolve this apparent discrepancy, we examined
MPP release via reversal of transport by DAT and
MPP toxicity in COS cells expressing the various
mutant DATs, which isolated the di¡erent transport
properties.
Fig. 3. MPP toxicity in COS cells expressing wild or 7S-A2
mutant DAT. After transfection of COS cells with wild or 7S-
A2 mutant DAT, cells were initially cultured for 24 h, then fur-
ther incubated with 0.1^1000 WM MPP for 2 days. After the
MPP treatment, cell number was assessed by WST-1. Points
and bars represent the mean þ S.E.M., n = 4. *P6 0.05 vs. con-
trol (without MPP).
Fig. 4. E¥ux of [3H]MPP through the transporter in COS
cells expressing wild or 7S-A2 mutant DAT. The DAT-ex-
pressed COS cells preloaded with [3H]MPP were washed and
incubated in the fresh medium with or without 100 WM unla-
beled MPP for various times. After incubation, the medium
was separated from cells, and the radioactivity in the medium
and that remaining in the cells were measured by liquid scintil-
lation counting. [3H]MPP e¥ux was expressed as % of initial
content prior to incubation. Points and bars represent the
mean þ S.E.M., n = 3. *P6 0.05 vs. wild-type (WT), #P6 0.05
vs. control (MPP minus) of each WT or 7S-A2 DAT.
Table 1
Functional characterization of Y251A, Y273A mutant dopamine transporter expressed in COS cells
Transporter [3H]DA uptake [3H]MPP uptake [3H]CFT bindinga
Km (WM) Vmax (pmol/Wg
protein/min)
Km (WM) Vmax (fmol/Wg
protein/min)
Kd (nM) Bmax (fmol/Wg
protein)
Wild 2.09 þ 0.15 3.96 þ 0.16 38.0 þ 5.1 353.7 þ 19.7 89.4 þ 56.2 97.4 þ 43.0
Y251A 0.92 þ 0.07b 0.74 þ 0.03b 9.0 þ 1.1b 57.1 þ 2.0b 460.7 þ 288.5 73.1 þ 39.9
Y273A 2.03 þ 0.07 0.57 þ 0.05b 35.2 þ 4.2 96.4 þ 4.6b 272.5 þ 90.1 129.9 þ 35.3
Values represent the mean þ S.E.M (n = 3).
aBinding of [3H]CFT ((3)-2L-carbomethoxy-3L-(4-£uorophenyl)-tropane), a cocaine analog, was performed using whole cell cultures
placed on ice in KRH with 4 nM [3H]CFT (3085.8 GBq/mmol, NEN DuPont), as previously described [13,14]. Speci¢c binding was
calculated by subtracting the non-speci¢c binding determined in the presence of 100 WM cocaine.
bSigni¢cantly di¡erent from Wild at P6 0.05.
BBAMCR 14346 8-9-98
S. Kitayama et al. / Biochimica et Biophysica Acta 1404 (1998) 305^313 309
The di¡erences in reverse transport through wild
versus 7S-A2 mutant DATs are shown in Fig. 4. 7S-
A2 mutant DAT demonstrated a slight increase in
e¥ux of MPP over 15 min incubated periods.
When unlabeled MPP was present in the extracel-
lular medium, release of [3H]MPP decreased in
COS cells expressing wild DAT. This change could
re£ect an increase in homo-exchange, assuming that
the ratio of intracellular [3H]MPP to unlabeled
MPP decreased during incubation periods due to
the uptake of unlabeled MPP, resulting in the net
increase of intracellular MPP (unlabeled MPP
plus [3H]MPP). In COS cells expressing 7S-A2 mu-
tant DAT, the addition of unlabeled MPP to the
incubation medium caused a decrease in [3H]MPP
e¥ux. In light of the above hypothesis, these results
suggest that 7S-A2 mutant DAT facilitates homo-ex-
change. Similar association and dissociation constant
for the binding of MPP to wild and 7S-A2 mutant
DATs were observed (data not shown). Taken to-
gether with MPP toxicity data comparing wild
and 7S-A2 mutant DAT-expressing COS cells, e¥ux
of MPP through the transporter may be important
factor in its toxicity.
Table 1 shows the uptake of [3H]DA and
[3H]MPP and [3H]CFT binding in COS cells ex-
pressing the Y251A and Y273A mutant DATs.
Y251A mutant DAT showed an increased a⁄nity
(Km) for [3H]DA and [3H]MPP uptake with de-
creased Vmax, whereas Y273A mutant DAT showed
a decrease in Vmax for [3H]DA and [3H]MPP uptake
without changing Km. The dissociation constant (Kd)
for [3H]CFT binding was increased in COS cells ex-
Fig. 5. Comparison of the MPP toxicity in COS cells express-
ing the Y251A and Y273A mutant DAT to the wild-type.
MPP toxicity was assessed by counting cell number after incu-
bation with MPP using WST-1, and expressed as % of control
(without MPP) in each cells expressing wild or mutant DATs.
Points and bars represent the mean þ S.E.M., n = 4. *P6 0.05
vs. control (without MPP).
Table 2
Relationship of reverse transport and MPP toxicity in COS cells expressing wild or mutant rat dopamine transporters
Transporter [3H]MPP uptakea [3H]MPP e¥uxb MPP
toxicityc
Km (WM) Vmax (fmol/Wg protein/min) (% of initial content/2 min) (vWT)
Experiment 1
Wild 16.36 þ 2.70 1.00 18.69 þ 0.68
7S-A2 14.80 þ 2.19 3.18 þ 0.53 24.22 þ 0.733 +5.53 s
Experiment 2
Wild 38.0 þ 5.1 1.00 30.92 þ 1.48
Y251A 9.0 þ 1.1 0.16 þ 0.01 27.53 þ 0.49 33.39 C
Y273A 35.2 þ 4.2 0.27 þ 0.01 37.47 þ 2.07 +6.55 s
Experiment 3
Wild 19.74 þ 4.34 1.00 31.28 þ 1.12
Y533A 9.48 þ 1.96 0.81 þ 0.10 32.225 þ 2.04 +0.94 C
Y533F 50.94 þ 11.57 2.26 þ 0.51 39.29 þ 0.98 +8.00 s
aExpt. 1 was from [13] and Expt. 3 was from [15].
b[3H]MPP e¥ux was determined during initial 2-min incubation after loading and washing the cells, and expressed as % of loaded
[3H]MPP. Values are the mean þ S.E.M, n = 3^4.
cMPP toxicity was expressed by comparing with COS cells expressing wild DAT (WT). s, decreased sensitivity below WT; C, simi-
lar sensitivity to WT.
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pressing Y251A and Y273A mutant DATs, but not
signi¢cantly due to large variations. However, the
Bmax values for [3H]CFT binding did not change,
suggesting that level of expression in mutant DATs
was normal. Sensitivity to MPP toxicity in COS
cells expressing Y251A mutant DAT was similar to
that in COS cells expressing wild DAT, while toxicity
in COS cells expressing Y273A mutant DAT de-
creased (Fig. 5). Again, we examined the reverse
transport of [3H]MPP in COS cells expressing these
mutant DATs. [3H]MPP e¥ux through Y251A mu-
tant DAT was similar to that through wild DAT,
while that through Y273A mutant DAT slightly in-
creased (Table 2).
Recently, we have demonstrated that the replace-
ment of tyrosine-533 lying in the 11th putative trans-
membrane region by alanine (Y533A) causes an in-
creased a⁄nity for MPP without changing Vmax,
whereas replacement by phenylalanine (Y533F)
caused a decreased a⁄nity with an increased Vmax
for MPP [15]. COS cells expressing Y533A mutant
DAT revealed a sensitivity to MPP toxicity similar
to that of COS cells expressing wild DAT (Fig. 6A).
On the other hand, COS cells expressing Y533F mu-
tant DAT revealed less sensitivity to MPP toxicity.
Furthermore, Y533F, but not Y533A, mutant DAT
showed increased e¥ux activity (Fig. 6B).
Table 2 summarized the uptake and reverse trans-
port of MPP and the sensitivity to MPP toxicity in
COS cells expressing wild or mutant DATs. Even at
the increased MPP uptake velocity, if e¥ux was
facilitated, MPP toxicity decreased. The ¢nding
that even with the decreased Vmax for MPP uptake,
increased a⁄nity for MPP uptake facilitates its tox-
icity suggest that a⁄nity rather than velocity may be
the critical factor in MPP toxicity. Given all the
above data, it is possible that re-distribution of
MPP due to in£ux/e¥ux turnover through the
transporter may be important for MPP toxicity ex-
pression.
4. Discussion
Systemic administration of MPTP causes selective
cell death of dopaminergic neurons in the brain.
There is a line of evidence indicating di¡erent sensi-
tivities to MPTP between species. Species di¡erences
Fig. 6. MPP toxicity (A) and [3H]MPP e¥ux (B) in COS cells expressing wild or Y533 mutant DATs. (A) After 1 h incubation of
cells with various concentrations of MPP, cells were washed and incubated with fresh medium without MPP for 3 h. LDH release
into the medium during the latter stage of incubation was determined. Points and bars represent the mean þ S.E.M., n = 4. *P6 0.05
vs. control (without MPP). (B) COS cells expressing wild or mutant DATs were preloaded with [3H]MPP. After washing, cells were
incubated with fresh medium for 2 min, and the e¥ux of radioactivity was determined by liquid scintillation counting. Values repre-
sent the mean þ S.E.M., n = 3. *P6 0.05 vs. wild-type (WT).
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in MAOB activity, which catalyzes MPTP to a toxic
metabolite, MPP, has been proposed as a mecha-
nism a¡ecting sensitivity to MPTP. Recently, Gio-
vanni et al. [17,18] demonstrated that, despite similar
levels of MAOB activity in rat and mouse brain,
mouse has greater sensitivity to MPTP toxicity
than rat. They explained that although transport of
MPP to the dopaminergic neuron was approxi-
mately the same, longer term retainment of MPP
was observed in mouse brain, possibly due to slower
clearance. This may be achieved by glial re-uptake of
MPP, slower transport into vessels through the spe-
ci¢c transporter on endothelial cells, or by some un-
known mechanism. Transporter in plasma mem-
branes of dopaminergic neuronal cells, i.e. DAT,
may a¡ect the clearance of MPP from cytosol.
We have demonstrated the bi-directional transport
of DA and MPP through DAT in COS cells and
Xenopus laevis oocytes expressing rat DAT [11,12],
suggesting that the reverse transport of MPP via
DAT might a¡ect its cytosolic clearance and, thus,
its toxicity.
In the present study, we examined the relationship
between MPP toxicity and DAT activity in COS
cells expressing wild DAT or various mutant
DATs, which showed di¡erent transport properties.
Given the data presented here, we concluded that
enhanced reverse transport of the toxin by DAT re-
duces sensitivity, suggesting that bi-directional trans-
port via DAT may be an important factor for MPP
toxicity expression.
Pi£ et al. [10] compared transport properties of
human DAT and NET expressed in di¡erent cell
lines to explain di¡erent sensitivities to MPTP
among dopaminergic and adrenergic neurons. De-
spite di¡erent transport activity for di¡erent sub-
strates, such as DA, norepinephrine and MPP,
DAT showed similar uptake velocity for DA and
MPP, while NET showed a lower MPP uptake
velocity than norepinephrine in contrast to the higher
apparent a⁄nity of NET for MPP than DAT. They
suggested from these results that the uptake velocity
of MPP is more important for its toxicity than its
a⁄nity. Contrary to this ¢nding, we demonstrated
that COS cells expressing mutant DAT which re-
vealed a marked increase in uptake velocity, such
as 7S-A2 and Y533F, shows less sensitivity to
MPP toxicity. Comparing a⁄nity and uptake veloc-
ity for MPP with toxicity revealed that increased
velocity did not correlate well with toxicity, while
decreased a⁄nity (Km) paralleled decreased sensitiv-
ity to MPP toxicity. These results suggest that the
a⁄nity of the transporter may be a critical factor in
MPP toxicity. The reason for the discrepancy be-
tween Pi£’s results and ours is unclear. Since they did
not examine MPP toxicity in the cells expressing the
DAT and NET [10], we speculate that cell lines for
expression of the transporter may a¡ect MPP tox-
icity, resulting from di¡erent levels of transport ac-
tivity due to cell-speci¢c environment for the trans-
porter in the plasma membrane.
Our previous investigations [13^15] of the struc-
ture^function relationship of DAT by site-directed
mutagenesis suggest that the MPP recognition site
might be di¡erent from the DA recognition sites,
suggesting a possible strategy for developing a spe-
ci¢c medicament for dopaminergic neuron toxins by
preventing their transport without a¡ecting DA up-
take. In addition to the neuroprotective mechanism
of vesicular monoamine transporter which has been
demonstrated to sequester MPP [19], the present
study suggests that facilitation of toxin extrusion
via DAT may attenuate its toxicity.
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